Stocktoria
Sintx Technologies, Inc. SINT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-02-11
Sintx Technologies, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 45.3% | 71.9% | 70.2% | 83.0% | 25.9% |
| Operating margin | -1053.1% | -486.6% | -508.5% | -726.1% | -1752.5% |
| Net margin | -1018.1% | -381.8% | -314.4% | -771.2% | -1536.1% |
| FCF margin | -860.1% | -323.2% | -557.5% | -747.5% | -2288.9% |
| Return on assets | -109.0% | -117.1% | -53.8% | -76.3% | -42.6% |
| Return on equity | -353.8% | -283.1% | -94.2% | -211.1% | -54.1% |
| Debt / equity | — | — | — | 0.06× | — |
| Current ratio | 1.51 | 2.28 | 1.90 | 0.89 | 5.47 |
| Revenue growth | -64.7% | 9.9% | 68.3% | 157.6% | 2.0% |
Source: SEC EDGAR filings · CIK 0001269026 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.